Myocardial bridging and prognosis: more evidence but jury still out

Myocardial bridging and prognosis: more evidence but jury still out.

Myocardial bridging (MB) is a congenital variant of coronary anatomy in which a segment of a major epicardial coronary artery that normally has an epicardial course runs intramurally through the myocardium beneath the muscle bridge. It occurs most frequently in the mid-portion of the left anterior descending (Figure 1). It is also called ‘tunneled artery’. Geiringer first presented an in-depth ...

Splinting poststroke: the jury is still out.

Splinting Poststroke: the Jury Is Still Out To the Editor: In the article abstract by Lannin et al,1 the authors claim “the practice of routine splinting soon after stroke should be discontinued.” Their presented data does not show this. The stated aim was to determine the effect of splinting “on contracture in the wrist and long finger flexor muscles”1 without defining ‘contracture’. Participa...

Triclocarban and Health: the Jury Is Still Out

In a recently published report, Poole et al. utilized a crossover design to determine the effect of nonprescription antimicrobial exposure on the human microbiome (1). After an initial washout phase, participants were provided either products that contained TCS or products without TCS for use over a 4-month period, followed by a switch to the opposite exposure regimen for another 4 months. Typi...

Osteoporosis and ERT--the jury is still out.

Reply to “Triclocarban and Health: the Jury Is Still Out”

Lauren Pischel,a Angela C. Poole,b,d Catherine Ley,a Gina Suh,a Julia K. Goodrich,b Thomas D. Haggerty,a Ruth E. Ley,b,d Julie Parsonnet,a,c Department of Medicine, Stanford University School of Medicine, Stanford, California, USAa; Department of Molecular Biology and Genetics, Cornell University, Ithaca, New York, USAb; Department of Health Research and Policy, Stanford University School of Me...